Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 1,050 | 0 | 1,252 | 976 | 1,056 |
| Cost of Goods | 1,127 | N/A | 1,066 | 1,134 | 1,077 |
| Gross Profit | -77 | N/A | 186 | -159 | -20 |
| Operating Expenses | 1,284 | 0 | 1,076 | -1,000 | 1,179 |
| Operating Income | -1,235 | N/A | -824 | -1,100 | -1,123 |
| Interest Expense | 1 | 0 | 0 | 0 | 0 |
| Other Income | -36 | 0 | 109 | 1,100 | 129 |
| Pre-tax Income | -1,271 | 0 | -715 | 0 | -994 |
| Net Income Continuous | -1,271 | N/A | -715 | N/A | -994 |
| Net Income | $-1,271 | $N/A | $-715 | $N/A | $-994 |
| EPS Basic Total Ops | -0.60 | N/A | -0.20 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.35 | N/A | -0.21 | N/A | -0.29 |
| EPS Diluted Total Ops | -0.60 | N/A | -0.20 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.35 | N/A | -0.21 | N/A | -0.29 |
| EBITDA(a) | $-1,235 | $N/A | $-189 | $1,181 | $-1,123 |